Sotera Health (SHC.US) was first covered by Piper Sandler, which gave it a neutral rating, with a target price of $13.00.
Sotera Health Analyst Ratings
Barclays: Maintaining the Sotera Health (SHC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $19.00 to $14.00.
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings
Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18
Sotera Health Analyst Ratings
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target Is $15.50
Sotera Health Analyst Ratings
Sotera Health (SHC) Receives a Buy From RBC Capital
Sotera Health Analyst Ratings
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating
Sotera Health Analyst Ratings
RBC Raises Price Target on Sotera Health to $22 From $18, Keeps Outperform Rating
Keybanc Maintains Overweight on Sotera Health, Lowers Price Target to $23
Sotera Health Analyst Ratings
No Data